Induction of human interleukin-1 by a product of Staphylococcus aureus associated with toxic shock syndrome
about
Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II moleculesFar East Scarlet-Like Fever: A Review of the Epidemiology, Symptomatology, and Role of Superantigenic Toxin: Yersinia pseudotuberculosis-Derived Mitogen AThe retrovirus/superantigen hypothesis of multiple sclerosis.Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibitionStaphylococcal enterotoxin type A internal deletion mutants: serological activity and induction of T-cell proliferation.Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release.Role of T cells and gamma interferon during induction of hypersensitivity to lipopolysaccharide by toxic shock syndrome toxin 1 in miceRole of antigen-presenting cells in activation of human T cells by the streptococcal M protein superantigen: requirement for secreted and membrane-associated costimulatory factorsGram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes.Biological activities of staphylococcal enterotoxin type A mutants with N-terminal substitutionsA toxic shock syndrome toxin 1 mutant that defines a functional site critical for T-cell activationSoluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism.Enhancement of endotoxin-induced isolated renal tubular cell injury by toxic shock syndrome toxin 1.Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria.The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells.Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferonEmerging drugs for the treatment of sepsis.Induction of nitric oxide synthase activity by toxic shock syndrome toxin 1 in a macrophage-monocyte cell line.Synergistic induction of interleukin-1 by endotoxin and toxic shock syndrome toxin-1 using rat macrophages.A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1Immunological protection of rabbits infected with Staphylococcus aureus isolates from patients with toxic shock syndrome.Established macrophagelike cell lines synthesize interleukin-1 in response to toxic shock syndrome toxin.Superantigen-mediated differentiation of bovine monocytes into dendritic cellsUltrafiltration to reject human interleukin-1-inducing substances derived from bacterial culturesStaphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.Temporal sequence and kinetics of proinflammatory and anti-inflammatory cytokine secretion induced by toxic shock syndrome toxin 1 in human peripheral blood mononuclear cells.Intravenous immunoglobulin inhibits staphylococcal toxin-induced human mononuclear phagocyte tumor necrosis factor alpha production.Bacterial pyrogenic exotoxins as superantigens.Binding competition of toxic shock syndrome toxin 1 and other staphylococcal exoproteins for receptors on human peripheral blood mononuclear cells.Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo.Release of interleukin-1 beta associated with potent cytocidal action of staphylococcal alpha-toxin on human monocytes.Effect of toxic shock syndrome toxin 1 on chicken embryos.Competitive, enzyme-linked immunosorbent assay for toxic shock syndrome toxin 1.Temporal relationship of cytokine release by peripheral blood mononuclear cells stimulated by the streptococcal superantigen pep M5.Identification of functional antigenic segments of toxic shock syndrome toxin 1 by differential immunoreactivity and by differential mitogenic responses of human peripheral blood mononuclear cells, using active toxin fragments.Targeting of superantigens.Characterization of human T cells reactive with the Mycoplasma arthritidis-derived superantigen (MAM): generation of a monoclonal antibody against V beta 17, the T cell receptor gene product expressed by a large fraction of MAM-reactive human T cellInterleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue.T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor.Distribution of interleukin-1 receptor antagonist genotypes in sudden unexpected death in infancy (SUDI); unexplained SUDI have a higher frequency of allele 2.
P2860
Q24609256-F694ACC0-8935-4551-A3AA-10F8C5F6AD91Q26773071-D4AE6393-1402-4974-991C-2EDF0855ADA3Q30317136-BD5A144E-3F76-4C82-86DA-0706C92FF686Q33449039-D881F027-A4C3-481E-8A45-96600F160380Q33596933-0E55E525-19AE-4D01-A2CB-E398CF623C8AQ33617692-99F5BAC6-525E-4E5F-A1FE-B34A2953C605Q34006170-F6998571-8DC4-49A0-B0E1-65EA4C0B384FQ34525449-72D96887-699E-4156-8F25-80E054C783A2Q34528810-99650D75-46A2-4208-B387-5159C73E3F21Q35415482-A881E976-A2AC-4047-9212-C9BC1DA726DFQ35415621-87E5D11B-A42D-4B0A-96AF-AAD2041081E3Q35819571-52F0429B-B28A-4878-BCB5-8A265EB7EEA5Q35835708-95EE354A-B103-4769-82D3-7C26F462D7C7Q36310840-4C6101D5-21A7-4B37-9475-54DEAAA79E9FQ36350439-3F51E820-A87B-4084-892C-71D4712B6E8BQ36354568-E485E064-DFE3-4476-82EB-C5305E46DF02Q36407391-C56828E7-AE73-4FCA-B4E9-12B443E4DC5CQ36877850-650CDEBD-A4A6-44BA-9067-6EC6735A3645Q37008583-D7B90079-FABB-4F53-834E-3069130A43F0Q37018132-9D0BF5DA-4C85-41DF-A184-12EB010D4CACQ37026931-0EB87197-5C5B-4980-8D3B-6567BB607AA8Q37031609-80B6060E-6635-443A-B4C5-BE5D1D2B60F7Q37130175-EB20ED6E-477A-4C39-9C2E-F3E942A55A53Q37215360-79C9EB64-E660-4143-805E-352B84EB268EQ37953740-552E4437-A58C-48F8-9A5A-3D2092E98D52Q39522923-363CD470-BC34-453E-802E-B71515D3FE66Q39827269-3BDB8023-F895-408E-A76A-71B1A9C5F65AQ39827387-99C203E5-DE7E-4D2D-9094-4B30BCCEC6DFQ40155077-61171B91-4B78-430C-AF6C-6094545B8F2AQ40157133-942AC9F0-81B4-4666-B42A-A03152A20882Q40160139-016C0EED-A34F-4051-84E6-4ED3C101FD83Q40167539-9D81C8C1-1BA2-40B7-B6EB-A62A19A21D95Q40203604-A2FF2CBE-BB17-449A-A07B-2B1B1DBC8BCDQ40270122-495ACCC8-AE45-425C-ADD6-42CA8201E440Q40429670-D31A7235-1D99-4A3C-B878-7A0E2194C664Q40612401-519EE8E5-D99D-4CAD-8451-B67D3D3110F4Q41662766-AAFBC0EF-307A-4A92-B3B8-951520539BEAQ41893697-5F2A4697-B242-4C1A-93CF-4356E8372ACEQ42768501-7887E26F-DF79-46F5-8C29-ACF2FC4CF72EQ54445408-8369E719-9207-47BB-BB18-9999EFBC141E
P2860
Induction of human interleukin-1 by a product of Staphylococcus aureus associated with toxic shock syndrome
description
1984 nî lūn-bûn
@nan
1984 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Induction of human interleukin ...... ated with toxic shock syndrome
@ast
Induction of human interleukin ...... ated with toxic shock syndrome
@en
Induction of human interleukin ...... ated with toxic shock syndrome
@nl
type
label
Induction of human interleukin ...... ated with toxic shock syndrome
@ast
Induction of human interleukin ...... ated with toxic shock syndrome
@en
Induction of human interleukin ...... ated with toxic shock syndrome
@nl
prefLabel
Induction of human interleukin ...... ated with toxic shock syndrome
@ast
Induction of human interleukin ...... ated with toxic shock syndrome
@en
Induction of human interleukin ...... ated with toxic shock syndrome
@nl
P2093
P2860
P356
P1476
Induction of human interleukin ...... ated with toxic shock syndrome
@en
P2093
C A Dinarello
P2860
P304
P356
10.1172/JCI111334
P407
P577
1984-05-01T00:00:00Z